Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Neoral

Generic name: Cyclosporine

FDA application holder: Novartis

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Neoral?
Neoral is a brand name of Cyclosporine, a prescription medicine. The FDA NDC Directory lists 3 Neoral products in 3 strengths and forms.
Who makes Neoral?
Novartis holds the FDA application for Neoral (NDA050715, approved July 14, 1995).
Is there a generic or store brand of Neoral?
Yes. The FDA NDC Directory lists 17 other products with the same active ingredients, strength and form as a Neoral product, 15 of them generic. Ask your pharmacist whether one is right for you.
What do pharmacies pay for Neoral?
CMS lists a National Average Drug Acquisition Cost (NADAC) for 2 Neoral strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
Has Neoral been recalled?
FDA enforcement reports list 1 recall of Neoral products; the newest started September 16, 2022. A recall usually concerns specific lots, not every product.

What Neoral is

Each Neoral product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Cyclosporine · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
cyclosporine 100 mg
capsule, liquid filled (oral)
Neoral 8 products, 8 companies DailyMed
cyclosporine 100 mg/mL
solution (oral)
Neoral 1 product, 1 company DailyMed
cyclosporine 25 mg
capsule, liquid filled (oral)
Neoral 8 products, 8 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Cyclosporine →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Neoral products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA050715NovartisJuly 14, 19952
NDA050716NovartisJuly 14, 19951

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Neoral, by strength and form
Strength and formGeneric or brandPharmacies pay
cyclosporine 100 mg
capsule, liquid filled
Brand: Neoral $11.77 per capsule
Generic of the same strength and form: $1.25 per capsule
cyclosporine 25 mg
capsule, liquid filled
Brand: Neoral $2.95 per capsule
Generic of the same strength and form: $0.3309 per capsule

NADAC list of November 4, 2026; these prices took effect on July 8, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list Neoral

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Neoral products.

Recalls

From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. September 16, 2022 · Class II · Terminated · D-1543-2022

    CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.

    Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton, Mfg by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, NDC # 0078-0246-15. — Novartis Pharmaceuticals Corporation

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers